19.06.2023 17:45:09
|
Shareholders Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
HBM Healthcare Investments AG
/ Key word(s): AGMEGM
At todays ordinary Shareholders Meeting of HBM Healthcare Investments Ltd the shareholders approved all proposals submitted by the Board of Directors. A total of about 32% of all shares were represented at the Shareholders Meeting. The Chairman of the Board of Directors Hans Peter Hasler and the existing board members Dr Rudolf Lanz, Mario G. Giuliani, Dr Stella X. Xu and Dr Elaine V. Jones were re-elected for a further one year term. The existing members of the Compensaiton Committee Mario G. Giuliani, Dr Stella X. Xu and Dr Elaine E. Jones were also re-elected for a further one year term. Furthermore, the shareholders approved the proposed compensation to the Board of Directors and to the Management. Further, the Shareholders Meeting approved a par value repayment of CHF 7.50 per share. The cash payment will be made on 7 August 2023. The registered shares with entitlement to the distribution will be traded for the last time on 2 August 2023 (from 3 August 2023 without, ex-date). Further, the Shareholders approved the amendments of the articles of association according to the motion of the Board of Directors. Contact
End of Media Release |
Language: | English |
Company: | HBM Healthcare Investments AG |
Bundesplatz 1 | |
6300 Zug | |
Switzerland | |
Phone: | +41438887171 |
Fax: | +41438887172 |
E-mail: | info@hbmhealthcare.com |
Internet: | https://www.hbmhealthcare.com |
ISIN: | CH0012627250 |
Valor: | 1262725 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1660653 |
End of News | EQS News Service |
|
1660653 19.06.2023 CET/CEST
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu HBM Healthcare Investments AGmehr Nachrichten
18.12.24 |
Successful IPO of HBM portfolio company Sai Life Sciences on the Indian stock exchanges NSE and BSE increases NAV per HBM share by 3.2 percent (EQS Group) | |
18.12.24 |
Erfolgreicher Börsengang des HBM-Portfoliounternehmens Sai Life Sciences an den indischen Börsen NSE und BSE erhöht NAV pro HBM-Aktie um 3.2 Prozent (EQS Group) | |
16.12.24 |
Key Figures 15.12.2024 (EQS Group) | |
02.12.24 |
Key Figures 30.11.2024 (EQS Group) | |
18.11.24 |
Key Figures 15.11.2024 (EQS Group) | |
04.11.24 |
Key Figures 31.10.2024 (EQS Group) | |
21.10.24 |
HBM Healthcare Investments publishes Half-Year Report as at 30 September 2024 with key figures for the first six months of the 2024/2025 financial year (EQS Group) | |
21.10.24 |
HBM Healthcare Investments publiziert Halbjahresbericht per 30. September 2024 mit Kennzahlen für die ersten sechs Monate des Geschäftsjahrs 2024/2025 (EQS Group) |